NIPT is the new Non-Invasive Prenatal Test on maternal blood to safely and reliabily screen pregnancies for the most common fetal chromosome anomalies Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome) and Trisomy 13 (Edwards syndrome).
Also the sex of the baby is determined.
NIPT is much more reliable than the classical first trimester screening or triple test. Furthermore, NIPT is much safer than the invasive test procedures such as amniocentesis and chorionic villus sampling, which have a miscarriage risk of 1%.
